Top Markets
Coin of the day
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NOVO-B
Rang in aandelen #94
Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the... Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
Aandeelprijs
$44.42
Marktkapitalisatie
$197.32B
Verandering (1 dag)
-0.30%
Verandering (1 jaar)
-20.41%
Land
DK
Handel Novo Nordisk A/S (NOVO-B)

Categorie

Koersgeschiedenis voor Novo Nordisk A/S (NOVO-B)
Hoogste slotkoers: $46.13 op 2026-09-01

Laagste slotkoers: $2.18 op 2001-06-01
Koersgeschiedenis van Novo Nordisk A/S van 2001 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -0.98%
2025 -52.90%
2024 4.17%
2023 52.14%
2022 18.40%
2021 58.24%
2020 22.06%
2019 25.41%
2018 -13.27%
2017 49.04%
2016 -38.00%
2015 26.90%
2014 26.23%
2013 10.09%
2012 43.00%
2011 5.11%
2010 62.81%
2009 25.51%
2008 -19.26%
2007 58.83%
2006 48.63%
2005 3.55%
2004 36.73%
2003 27.97%
2002 -21.13%
2001 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$1.14K 52.16%
US
$266.99 50.50%
US
$261.63 20.23%
US
$476.79 37.99%
CH
$144.70 78.60%
US